An official website of the United States government
Different Types of Massage Therapy to Reduce Anxiety during Chemotherapy Infusion in Patients with Cancer
Trial Status: active
This clinical trial tests how well different types of massage therapy works to reduce anxiety during chemotherapy infusions in patients with cancer. Many cancer patients experience moderate to severe anxiety and anxiety can worsen by the anticipation of medical procedures that patients have to receive, particularly chemotherapy. Massage therapy, as a complementary treatment, has shown promise in lessening both physical and psychological symptoms associated with cancer and its treatments. Research has also shown the benefits of massage therapy in reducing pain, stress, anxiety, nausea (upset stomach), fatigue (tiredness), and depression in cancer patients. Different types of massage therapy may potentially reduce some cancer patients’ symptoms, enhance their treatment, and reduce treatment related side effects.
Inclusion Criteria
Participant must be 18 years of age or older at time of consent
The study is open to all participants regardless of gender, race, or ethnicity
Participants should have had at least 1 cycle of the chemotherapy regimen at the time of recruitment
Participant must have a baseline anxiety score > 3 on the Visual Analog scale (VAS)
Scheduled for at least six more infusion sessions
Participant has had complete blood count (CBC) drawn within 30 days of baseline assessment
Exclusion Criteria
Platelet count less than 20,000 k/uL. Patients taking anticoagulants are not excluded, as the protocol for massage in infusion ensures that deep pressure massage is never performed, and patient’s massage will not exceed a 3 on the Walton scale
Absolute neutrophil count (ANC) less than 0.5 k/uL
Patient has had a deep vein thrombosis (DVT) within the past 3 months
Patient has received radiation therapy to any of the targeted areas within the past 90 days
Patients using a cold therapy device must be willing to discontinue use of any device for the entire duration of the study (5 infusion sessions). Patients must agree not to resume use of cold therapy devices immediately after massage sessions or at any other time during the study period
Had surgery on their foot, leg, head, neck, shoulder, hands, or arms within the past 3 months, or has incomplete healing
Participant has rashes, open wounds, or any skin conditions that could be exacerbated by massage
Known allergies to jojoba oil or any other substances that may be used during the massage therapy sessions
Ongoing uncontrolled active psychiatric condition that would interfere in the conduct of the study (e.g., mood disorders, anxiety, psychosis disorders, or substance use) with additional confirmation provided by the principal investigator (PI), as needed
In order to minimize undue influence and coercion, the study team will not personally solicit an employee for participation: An employee who is under the direct/indirect supervision of the principal investigator (PI)/a co-investigator/the study manager and a direct study team member
Pregnancy
Any participants with bone metastasis
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07184294.
I. To assess the feasibility of 30-minute massages targeting various body regions among patients with cancer receiving anticancer therapy infusion.
II. Assess which type of massage is preferred by patients with cancer receiving anticancer therapy infusion.
SECONDARY OBJECTIVE:
I. To assess the change in anxiety levels after each type of massage therapy during infusion.
EXPLORATORY OBJECTIVE:
I. To evaluate changes in other symptoms, such as: pain, fatigue, nausea, depression, and overall well-being, using data obtained from the Edmonton Symptoms Assessment scale (ESAS) after each type of massage therapy.
OUTLINE:
Patients receive massage therapy according to a randomized schedule to the feet/legs (FL), head/neck/shoulder (HNS), hands/arms (HA), combination of all three groups (FL, HNS, HA) or no massage therapy over 30 minutes for 5 chemotherapy sessions total on study. Patients also undergo saliva sample collection on study.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationCity of Hope Comprehensive Cancer Center